One state established a hemp growth program, one governor vetoed legislation expanding his state’s hemp program, and agencies in five states announced hemp policies or regulations. One county prosecutor announced CBD is illegal in his state. One city passed a one-year moratorium on new CBD businesses. Below is a review of the latest hemp legal changes listed state-by-state. Read More ›
It’s official — with Governor DeWine’s signature, Senate Bill 57 legalized hemp-derived products like cannabidiol (CBD) oil in the state of Ohio. With this law, Ohio catches up to several other states and the federal government in making products from this type of cannabis plant legal to sell and use without a recommendation from a physician and without purchase from a licensed medical marijuana dispensary. Read More ›
While marijuana remains illegal at the federal level, decriminalization of marijuana in over half the U.S. states has created many business opportunities and led to the creation of a multi-billion-dollar industry. Read More ›
According to the Centers for Medicare & Medicaid Services (CMS) final rule, effective September 16, 2019, long-term care (LTC) facilities can try to cut down on the cost of litigation by implementing a pre-dispute arbitration agreement with residents. Read More ›
Information Blocking and the API Standard: Proposed Rules Look to Shake-up Data in the Healthcare Industry
The Centers for Medicare and Medicaid Services (CMS) and the Office of the National Coordinator for Health Information Technology (ONC) released separate but connected proposed rules governing interoperability, information blocking, and the use of application programming interfaces (APIs) in the healthcare industry. Read More ›
Marijuana products liability claims are inevitable. As the marijuana industry increases in size, and more states eventually legalize its use for medical or recreational purposes, it will become a target of litigation. Although only a small number of cases have been filed, manufacturers, retailers, and others along the marijuana supply chain need to prepare for the inevitable increase in claims against the industry, specifically those arising out of products liability. Read More ›
Ask the Blogger
Do you have a topic that you would like discussed in a future blog article? Please let us know. If you have a confidential question regarding a blog article, please feel free to contact the article's author directly, or let us know if you would like for someone to contact you directly.
Brian F. Higgins is an associate in FBT's regulated business group with a focus on health care, and he has a history as corporate counsel to Medpace, Inc., a pharmaceutical clinical research organization.